PVRL2 anticorps

N° du produit ABIN1384013

L’anticorps Souris Monoclonal anti-PVRL2 a été validé pour FACS, ELISA et IP. Il convient pour détecter PVRL2 dans des échantillons de Humain. Il y a 2+ publications disponibles.

Aperçu rapide pour PVRL2 anticorps (ABIN1384013)

Antigène: PVRL2 (Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp PVRL2 est non-conjugé

Application: Flow Cytometry (FACS), ELISA, Immunoprecipitation (IP)

Clone: B-C12

Détail du produit anti-PVRL2 anticorps

Specificité: Recognises Nectin-2, the polio retrovirus receptor-2 (PRR2)

Purification: Ion exchange chromatography

Stérilité: 0.22 μm filtered

Immunogène: KG-1 cell line,Myeloma X63/AG.8653 x Balb/c spleen cells

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free

Agent conservateur: Without preservative

Stock: 4 °C

Stockage commentaire: Stable at +2-8°C for 12 months. For longer storage freeze aliquots.

Références pour anticorps anti-PVRL2 (ABIN1384013)

Lopez, Cocchi, Menotti, Avitabile, Dubreuil, Campadelli-Fiume: "Nectin2alpha (PRR2alpha or HveB) and nectin2delta are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D." dans: Journal of virology, Vol. 74, Issue 3, pp. 1267-74, (2000) (PubMed).

Lopez, Aoubala, Jordier, Isnardon, Gomez, Dubreuil: "The human poliovirus receptor related 2 protein is a new hematopoietic/endothelial homophilic adhesion molecule." dans: Blood, Vol. 92, Issue 12, pp. 4602-11, (1999) (PubMed).

Détails sur PVRL2

Antigène: PVRL2 (Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2))

Autre désignation: CD112

Sujet: HVEB, PRR2

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization